Overview

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)

Status:
Completed
Trial end date:
2009-08-14
Target enrollment:
Participant gender:
Summary
This study will test the safety of treating colorectal cancer with a combination of drugs. The current standard treatments of FOLFOX6 or CapeOx will be give in combination with the GSK investigational drug pazopanib.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Capecitabine
Fluorouracil
Oxaliplatin